SCHEMBL17034907

SCHEMBL17034907

O=P(c1ccccc1)(c1ccccc1)c1c2ccccc2c(-c2nc3ccccc3c3c2ccc2ccccc23)c2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
LMNA P02545 2/20 0.31
TYMS P04818 2/20 0.31
HPGD P15428 2/20 0.30
MAPK1 P28482 2/20 0.30
HIF1A Q16665 2/20 0.30
CYP3A4 P08684 1/20 0.30
TSHR P16473 1/20 0.30
CASP1 P29466 1/20 0.30
RAB9A P51151 1/20 0.30
CASP7 P55210 1/20 0.30
ATM Q13315 1/20 0.30
HSD17B10 Q99714 1/20 0.30
TOP2A P11388 1/20 0.30
MAPT P10636 1/20 0.30
CDK4 P11802 1/20 0.30
CCND1 P24385 1/20 0.30
HPRT1 P00492 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17035054 0.85 ESR1 (0.34) LMNAHPGDRAB9AMAPTMEN1
SCHEMBL19009820 0.84 NPSR1 (0.32) NPSR1LMNATYMSHPGDMAPK1
SCHEMBL19009821 0.82 NPSR1 (0.36) NPSR1LMNATSHRTOP2AMAPT
SCHEMBL19009855 0.82 TYMS (0.35) NPSR1LMNATYMSHPGDRAB9A
SCHEMBL18200622 0.81 DHODH (0.40) L3MBTL1TDP1LMNATSHRATM
SCHEMBL17034894 0.81 DHODH (0.40) L3MBTL1TDP1LMNATSHRATM
SCHEMBL18200623 0.81 DHODH (0.40) L3MBTL1TDP1LMNATSHRATM
SCHEMBL18200531 0.79 MAPT (0.33) NPSR1L3MBTL1TDP1LMNAHPGD
SCHEMBL17034902 0.78 MAPT (0.39) LMNAHPGDRAB9AMAPTALDH1A1
SCHEMBL18201270 0.78 NPC1 (0.38) L3MBTL1TDP1LMNATYMSRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 NPSR1 4453/4885L3MBTL1 1123/4885TDP1 3046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.